🇺🇸 FDA
Pipeline program

Colchicine 0.5 mg

ACT-GLOBAL_ICH_01

Phase 3 small_molecule active

Quick answer

Colchicine 0.5 mg for Intracerebral Hemorrhage is a Phase 3 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Intracerebral Hemorrhage
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials